federal enforcement actions, filings and court records, from official sources

••• ⚠️ Newsticker presented by CFExclusion.com ⚠️ ••• 🚨 FRAUD WATCH — Federal authorities announced charges against 16 noncitizens in alleged election-related crimes, including illegal voting and fraudulent voter registration; defendants remain presumed innocent.  • 🤖 AI SECURITY — Researchers report autonomous AI agents attempting hacking techniques against government websites, while malicious AI tools are increasingly being used in cyberattacks.  • 💻 ONLINE THEFT — The FBI says multiple suspects have been arrested in the ShinyHunters data-theft investigation following attacks involving stolen information and extortion.  • 🇺🇸 TRUMP — Trump announced a federal “Super Intelligence Force” to coordinate America’s AI strategy and maintain U.S. technological leadership.  • 🏛️ POLITICS — With one month until the midterms, control of Congress is tightening into a major national battle.  • 🔎 AI SCREENING — As fraud, stolen identities and automated attacks accelerate, AI-based scre

Records through Monday, October 12, 2026 DOJ · SEC · FTC · FDA · CFPB · CFTC · FINRA · OCC · Federal Register · CourtListener · SCOTUSblog

U.S. Food and Drug Administration · FDA enforcement report entry

FDA Class II: Cipla USA, Inc. — Cinacalcet Hydrochloride Tablets, 90 mg, 30 Tablets per bottle, Rx Only, Manufactured by: Cipla Ltd.

The U.S. Food and Drug Administration listed this entry in its enforcement reports on April 22, 2026. The source link opens the FDA’s recalls, market withdrawals and safety alerts page.

Read the official source on fda.gov →

Issued by: U.S. Food and Drug Administration
Document type: FDA enforcement report entry
Date: April 22, 2026
First recorded by CourtPulse: April 28, 2026 · all records that day
Category: FDA action (assigned by CourtPulse)

CourtPulse lists public records with a link to the official source. The title is shown as the source published it; this page adds no commentary.

More from U.S. Food and Drug Administration, within 7 days

FDA Class II: The Harvard Drug Group LLC — Memantine Hydrochloride Extended-Release, Capsules, 7 mg, 100 Capsules (10 x 10 blister packs), Rx o Apr 22, 2026 · FDA enforcement report entry
FDA Class II: Xiamen Kang Zhongyuan Biotechnology Co., Ltd. — QC Quality Choice, Menthol-Cough Suppressant Oral Anesthetic, Cough Drops, Honey Lemon Flavor, 30-co Apr 22, 2026 · FDA enforcement report entry
FDA Class II: SUN PHARMACEUTICAL INDUSTRIES INC — Fluocinonide, USP, 0.05% Cream, 15g tube, Rx only, Mfd by: Taro Pharmaceuticals Inc., Brampton, Onta Apr 22, 2026 · FDA enforcement report entry
FDA Class II: Xiamen Kang Zhongyuan Biotechnology Co., Ltd. — Discount Drug Mart Food Market, Cough Drops, Menthol- Cough Suppressant Anesthetic, Honey Lemon, 30- Apr 22, 2026 · FDA enforcement report entry
FDA Class II: Nephron SC, LLC — Albuterol Sulfate Inhalation Solution, 0.5%, 25 mg/5 mL (5 mg/mL*), 30x5 mL Sterile Unit-Dose Vials Apr 22, 2026 · FDA enforcement report entry
FDA Class II: Xiamen Kang Zhongyuan Biotechnology Co., Ltd. — QC Quality Choice, Menthol-Cough Suppressant Oral Anesthetic, Cough Drops, Sugar Free, Honey Lemon F Apr 22, 2026 · FDA enforcement report entry

Get records like this one daily by email →